# Prolonged Grief-Related Symptoms Among Young Individuals After Loss of a Parent or Sibling to Cancer: A Systematic Review and Meta-Analysis

**Authors:** Chen Ee Low, Jia Yang Tan, Weiling Amanda Tan, Jayanth Jayabaskaran, Emily Chen Fei Ni, Ga Eun Pang, Dawn Yi Xin Lee, Sean Loke, Hon Jen Wong, Chun En Yau, Ainsley Ryan Yan Bin Lee, Cyrus Su Hui Ho

PMC · DOI: 10.3390/jcm15031060 · Journal of Clinical Medicine · 2026-01-29

## TL;DR

This study finds that nearly half of young people who lose a parent or sibling to cancer experience prolonged grief symptoms, especially after losing a sibling.

## Contribution

The paper provides a meta-analysis of prolonged grief symptoms in young individuals after parental or sibling cancer-related loss, highlighting the need for better assessment tools.

## Key findings

- The pooled prevalence of prolonged grief-related symptoms was 48% among young individuals.
- Prolonged grief symptoms were more common after sibling death (59%) than parental death (28%).
- Risk factors included pre-existing depression, emotional difficulties, and insomnia.

## Abstract

Background/Objectives: Bereavement in childhood, adolescence, and young adulthood is associated with a range of grief responses, and a subset of bereaved individuals develop persistent or severe grief symptoms. Understanding the prevalence and risk factors of prolonged grief symptoms is important for guiding supportive care. Methods: We systematically searched PubMed, MedLine, Embase and PsycINFO for all studies comparing the prevalence and prognostic factors of prolonged grief-related symptoms among young individuals following parental or sibling death from cancer. Young individuals were defined as those not more than 25 years old before losing a parent or sibling to any cancer. Prolonged grief-related symptoms were defined as the presence of grief symptoms at least six months following the death of a parent or sibling of the bereaved person. Retrospective cross-sectional studies were included for evaluating prognostic factors affecting prolonged grief-related symptoms, but were not used for meta-analyses. Random-effects meta-analyses were conducted for the primary analysis. Results: From 1561 records identified, thirteen studies were included with five for quantitative pooling in meta-analysis. The pooled prevalence of self-reported prolonged grief-related symptoms was 48% (95% CI: 29–67%). Stratified analyses suggested a prevalence of 28% (95% CI: 7–65%) after parental death and 59% (95% CI: 45–72%) after sibling death. Factors associated with elevated prolonged grief-related symptoms included pre-existing depression, emotional difficulties, and insomnia. As no included studies conducted diagnostic clinical interviews, prolonged grief disorder according to the ICD-11 or DSM-5-TR criteria could not be assessed. Conclusions: Prolonged grief-related symptoms appear common among young individuals bereaved by loss of a parent or sibling to cancer, especially after sibling loss. However, interpretation remains limited by substantial heterogeneity, such as outcome measures, symptom thresholds, assessment time window, non-validated symptom measures, and predominance of cross-sectional studies. Future larger and methodologically rigorous studies using validated grief instruments across diverse settings are needed to clarify grief trajectories and guide developmentally appropriate intervention strategies.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** Prolonged Grief (MESH:D008133), insomnia (MESH:D007319), depression (MESH:D003866), death (MESH:D003643), Cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898307/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12898307/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898307/full.md

---
Source: https://tomesphere.com/paper/PMC12898307